TScan Therapeutics Inc. Common Stock (TCRX)
Stock · NASDAQ · Health Care
$0.231as of 10/16/2026
Price chart
Active signals
TCRX Signal Track Record
How signals performed across all stocks →What TCRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 43 | -1.8% | 47% | October 8, 2026 |
| Bollinger Band Breakout | 26 | -6.1% | 42% | July 1, 2026 |
| Bollinger Band Breakdown | 22 | -1.8% | 45% | October 6, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -9.5% | 33% | July 10, 2024 |
| Any 20-session window (baseline) | -3.0% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TCRX
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell t…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 138
- Website
- www.tscan.com
Fundamentals
- 1-day range
- $0.213$0.24
- Market cap
- $49.88M
- P/E (trailing)
- —
- P/E (forward)
- -0.38
- EPS (trailing)
- $-0.91
- Dividend yield
- —
- Beta
- 1.17
- Avg. volume
- 772.0K
How TScan Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 4, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
TScan Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TCRXTScan Therapeutics Inc. Common Stock$0.231▼ 3.35%Market cap $49.88MP/E —$0.2243$2.57
- TILInstil Bio Inc. Common Stock$5.91▼ 3.59%Market cap $49.37MP/E —$5.67$21.64
- ATYRaTyr Pharma Inc. Common Stock$0.174▼ 5.43%Market cap $49.22MP/E —$0.2$1.11
- INMBINmune Bio Inc. Common stock$1.57▼ 4.85%Market cap $50.78MP/E —$1.09$2.6
- OKYOOKYO Pharma Limited Ordinary Shares$1.41▼ 1.40%Market cap $51.94MP/E —$1.26$3.2
- EXOZeXoZymes Inc. Common Stock$4.09▲ 2.25%Market cap $47.57MP/E —$4.35$18.4
- MGXMetagenomi Therapeutics Inc. Common Stock$0.784▼ 7.22%Market cap $46.68MP/E —$0.86$3.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TCRX TScan Therapeutics Inc. Common Stock | $49.88M | — | $0.231 | ▼ 3.35% | $0.2243$2.57 |
| TIL Instil Bio Inc. Common Stock | $49.37M | — | $5.91 | ▼ 3.59% | $5.67$21.64 |
| ATYR aTyr Pharma Inc. Common Stock | $49.22M | — | $0.174 | ▼ 5.43% | $0.2$1.11 |
| INMB INmune Bio Inc. Common stock | $50.78M | — | $1.57 | ▼ 4.85% | $1.09$2.6 |
| OKYO OKYO Pharma Limited Ordinary Shares | $51.94M | — | $1.41 | ▼ 1.40% | $1.26$3.2 |
| EXOZ eXoZymes Inc. Common Stock | $47.57M | — | $4.09 | ▲ 2.25% | $4.35$18.4 |
| MGX Metagenomi Therapeutics Inc. Common Stock | $46.68M | — | $0.784 | ▼ 7.22% | $0.86$3.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- ZDRAVESKI ZORAN · October 1, 2026 · Grant300.0K
- MacBeath Gavin · October 1, 2026 · Grant1.00M
- Keith Woods · May 20, 2026 · Grant67.0K
- Gabriela Gruia · May 20, 2026 · Grant67.0K
- Barbara Klencke · May 20, 2026 · Grant67.0K
- Nicholson Garry A · May 20, 2026 · Grant67.0K
- Dorton Katina · May 20, 2026 · Grant67.0K
- BAKER JULIAN · May 20, 2026 · Grant67.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 32.17M
- Total value held
- $31.88M
- Institutional holders
- 57
- Unknown8.02M
- Unknown5.56M
- Unknown2.78M
- Unknown2.15M
- Unknown1.84M
- Unknown1.46M
- Unknown1.36M
- Unknown1.25M
- Unknown1.21M
- Unknown918.0K
See the full, filterable feed with live charts on the MarketWall dashboard.